ENGOT-EN1/FANDANGO
Study documentation (link to documents is only accessible with password to www.nsgo.org).
Click HERE for access.
|
Study sponsor |
NSGO |
|
NSGO-CTU Project Manager |
Mette Engell NSGO-CTU, Rigshospitalet, Copenhagen, Denmark +45 3545 3398 |
|
Study Chair |
Mansoor Raza Mirza +45 3545 3939 |
|
Drug |
Nintedanib |
|
Phase |
II |
|
Randomized trial |
Yes |
|
Type |
Double-blinded |
|
Total number of patients |
148 patients required |
|
Number of patients recruited |
Recruitment statistics – link |
|
Trial status |
Recruitment closed |
|
Date of first site activated |
16.11.2016 |
|
eCRF |
Open Clinica test – link (protected information – access only with login) Open Clinica Live – link (protected information – access only with login) |
|
Site list |
Site list addes soon (protected information – access only with login) |
|
Protocol summary |
ClinicalTrials.gov – link |
Click HERE for access.